Erica L. Andres

机构：Mayo Clinic in Arizona

发表论文 12 篇 · 总被引 3139 次 · h-index 5

代表论文

• Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease (2018 · mBio · 被引 1519)
• Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen (2017 · Proceedings of the National Academy of Sciences · 被引 1239)
• Small-Molecule Antiviral β- d - N 4 -Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance (2019 · Journal of Virology · 被引 355)
• Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model (2017 · American Journal of Physiology-Renal Physiology · 被引 11)
• Treatment Patterns and Outcomes for Patients with Classic Hodgkin Lymphoma (cHL) and Cardiomyopathy with Low Ejection Fraction (EF): Real-World Evidence (RWE) from 16 US Academic Centers (2023 · Blood · 被引 5)
• Small-Molecule Antiviral β-d-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance (2020 · UNC Libraries · 被引 5)